Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 22 Nov 2024
- Closes
- 23 Dec 2027, 23:59 UTC
- Value
- USD 350,000
- Reference
- RFA-HL-26-016
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)”. Submissions close on 23 December 2027, 403 days from today. The stated value is USD 350,000. Quote reference RFA-HL-26-016 in any correspondence with the buyer. FreeTender has recorded 459 notices from this buyer since 2023, 368 of them currently open. There are 389 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in product development and entrepreneurship. This specific Catalyze Enabling Technologies and Transformative Platforms initiative will support needed to rigorously validate transformative, multi-use platforms or technologies that can enable. Well-suited applications must offer the potential to significantly accelerate and/or transform the areas of early detection and screening, model development, clinical diagnosis, treatment, control, behavior, prevention or epidemiology. Proposed platforms and technologies may have widespread applicability but must be able to improve the outlook for HLBS-related diseases and disorders. Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
CFDA number(s): 93.233
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 459 notices from National Institutes of Health, going back to May 2023 — 368 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 389 open Healthcare & Pharma tenders in United States. This one closes in 403 days.
More from this buyer
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)· closes 5 Mar
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)· closes 5 Mar
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)· closes 17 Feb
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- Comprehensive Medical Services -FCI Pekin — General Health Care Services· closes 11 Feb
- Suction Apparatus, Surg — 40 each, NSN 6515016775151· closes 19 Nov
- Litter, Folding, Pole — 67 each, NSN 6530016631222· closes 18 Nov
- Blanket, Survival — 3000 each, NSN 6532015246932· closes 19 Nov
Explore United States
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка аппликаторов грязевыхГОСУДАРСТВЕННОЕ АВТОНОМНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ ОРДЕНА ТРУДОВОГО КРАСНОГО ЗНАМЕНИ "ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА № 1 Г. ЧЕЛЯБИНСК" · Russia
- Поставка лекарственных средств (растворов плазмозамещающих и перфузионных)ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ ПЕРМСКОГО КРАЯ "ПОЛАЗНЕНСКАЯ РАЙОННАЯ БОЛЬНИЦА" · Russia
- Поставка лекарственных препаратов МНН Десмопрессин, для льготной категории граждан на 2027 год (субвенция).СЛУЖБА РЕГУЛИРОВАНИЯ КОНТРАКТНОЙ СИСТЕМЫ В СФЕРЕ ЗАКУПОК РЕСПУБЛИКИ КАЛМЫКИЯ · Russia
- ПОСТАВКА ПРЕПАРАТА БЕКЛОМЕТАЗОН+ГЛИКОПИРРОНИЯ БРОМИД+ФОРМОТЕРОЛ для обеспечения граждан Российской Федерации, находящихся на территории Республики Бурятия, имеющих право на получение государственной социальной помощи в соответствии с Федеральным законом от 17 июля 1999 г. № 178-ФЗ «О государственной социальной помощи»РЕСПУБЛИКАНСКОЕ АГЕНТСТВО ПО ГОСУДАРСТВЕННЫМ ЗАКУПКАМ · Russia
- Лекарственный препарат для медицинского применения Кальция фолинатГОСУДАРСТВЕННОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "ЛИПЕЦКИЙ ОБЛАСТНОЙ ОНКОЛОГИЧЕСКИЙ ДИСПАНСЕР" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →